MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover the crucial role of genetic testing in diagnosing Retinitis Pigmentosa 39, guiding gene augmentation therapy, and preventing inherited blindness.
Discover the role of genetic testing in diagnosing Retinitis Pigmentosa 7 (RP7), creating personalized treatment plans, and guiding family planning decisions.
Discover LRAT-related retinitis pigmentosa, its diagnosis, and the importance of genetic testing for accurate prognosis, family planning, and future treatment options.
Discover the role of genetic testing in diagnosing and managing X-linked retinitis pigmentosa, sinorespiratory infections, and deafness for improved treatment and family planning.
Discover the role of genetic testing in diagnosing Rett Syndrome and its variants, such as Zappella, for early intervention, family planning, and improved outcomes.
Discover RPE65-related disorders, their diagnosis, and the role of genetic testing in managing these rare retinal dystrophies. Learn about gene therapy and multidisciplinary care…
Discover the importance of genetic testing in diagnosing and managing SCN5A-related disorders, guiding treatment decisions, and offering family screening for a healthier future.
Discover the importance of genetic testing in diagnosing and managing sensorineural deafness with mild renal dysfunction, enabling targeted therapies and informed family planning.